Literature DB >> 8590493

Decreased hypothalamic prostaglandin D2 and prostaglandin E2 contents during isoflurane anaesthesia in rats.

T Sato1, I Araki, T Kushikata, H Ohkawa, H Ishihara, A Matsuki.   

Abstract

This study was undertaken to evaluate the effect of isoflurane anaesthesia on the hypothalamic contents of both prostaglandin D2 and E2 which affect the sleep-wakefulness cycle. Sixty-three Wistar rats were divided into three equal groups, control, isoflurane and recovery groups. Twenty-one rats of the control did not receive isoflurane. In the other groups 21 rats received isoflurane 2% for 30 min and 21 received isoflurane 2% for 30 min and were allowed to recover their usual behaviours, including righting reflex, spontaneously. The hypothalamus was removed and the contents of PGD2 and PGE2 were measured by enzyme immunoassay. The PGD2 content in the hypothalamus was 397.9 +/- 226.0 pg.g-1 for the control group, 134.2 +/- 41.2 pg.g-1 for the isoflurane group and 269.1 +/- 124.6 pg.g-1 for the recovery group, respectively. The hypothalamic PGE2 contents were 381.4 +/- 139.0 pg.g-1 for the control group, 183.3 +/- 26.4 pg.g-1 for the isoflurane group and 312.2 +/- 96.0 pg.g-1 for the recovery group, respectively. The hypothalamic PGD2 and PGE2 contents in the isoflurane group were lower (P < 0.05) than those in the control and recovery groups, while both the PGD2 and PGE2 contents of the control and the recovery groups were similar. We conclude that decreased hypothalamic PGD2 and PGE2 contents may be related to some manifestations of general anaesthesia with isoflurane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590493     DOI: 10.1007/BF03011078

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  28 in total

1.  IDENTIFICATION OF A SMOOTH MUSCLE-STIMULATING FACTOR IN BOVINE BRAIN. PROSTAGLANDINS AND RELATED FACTORS 25.

Authors:  B SAMUELSSON
Journal:  Biochim Biophys Acta       Date:  1964-04-20

2.  Sleep-wake regulation by PGD2 and E2.

Authors:  O Hayaishi; H Matsumura; H Onoe; Y Koyama; Y Watanabe
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

3.  Brain RNA and hypophysectomy; a topographical study.

Authors:  W H Gispen; P Schotman; E R de Kloet
Journal:  Neuroendocrinology       Date:  1972       Impact factor: 4.914

4.  Immunoreactive dynorphin in pituitary and brain.

Authors:  A Goldstein; V E Ghazarossian
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

5.  Prostaglandin D2 induces sleep when infused into the cerebral ventricle of conscious monkeys.

Authors:  O Hayaishi; R Ueno; H Onoe; H Osama; I Fujita; H Nishino; Y Oomura
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1987

6.  Suppressive effect of prostaglandin (PG)D2 on pulsatile luteinizing hormone release in conscious castrated rats.

Authors:  F Kinoshita; Y Nakai; H Katakami; H Imura; T Shimizu; O Hayaishi
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

7.  Distinct localization of prostaglandin D2, E2 and F2 alpha binding sites in monkey brain.

Authors:  Y Watanabe; Y Watanabe; K Hamada; M C Bommelaer-Bayt; F Dray; T Kaneko; N Yumoto; O Hayaishi
Journal:  Brain Res       Date:  1989-01-23       Impact factor: 3.252

Review 8.  Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2.

Authors:  O Hayaishi
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

9.  Regional and species differences in endogenous prostaglandin biosynthesis by brain homogenates.

Authors:  M S Abdel-Halim; E Anggård
Journal:  Prostaglandins       Date:  1979-03

10.  PGD2 effects on rodent behavior and EEG patterns in cats.

Authors:  S G Laychock; D N Johnson; L S Harris
Journal:  Pharmacol Biochem Behav       Date:  1980-05       Impact factor: 3.533

View more
  1 in total

Review 1.  Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep.

Authors:  Tetsuya Kushikata; Kazuyoshi Hirota; Junichi Saito; Daiki Takekawa
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.